CASE Sta Barbara

download CASE Sta Barbara

of 29

Transcript of CASE Sta Barbara

  • 8/6/2019 CASE Sta Barbara

    1/29

    Western Visayas Sanitarium

    January 31, 2011

  • 8/6/2019 CASE Sta Barbara

    2/29

    yA.C

    y9 months old/FemaleyNew Lucena

    yCC: white patches on the face

  • 8/6/2019 CASE Sta Barbara

    3/29

    y 5 months prior to consult, mother noted white patchon the right preauricular area of the patient. Motherdidnt bother to seek consult.

    y 4 months prior to consult, white patches were noted tohave increase in size. No consult done. No remediesgiven.

    y 3 months prior to consult, lesions spread to the frontal

    and orbital areas. No change in color of the lesions. Noconsult done and no medications given.

  • 8/6/2019 CASE Sta Barbara

    4/29

    y 2 months prior to consult, there was progression of thesize of the lesions involving the cheek areas. Noconsult done. No medications were given.

    y Persistence of signs until the day of consult promptedthe mother to seek consult.

    y Pertinent negatives: pruritus, crusting, no previous useof topical cream or ointments

  • 8/6/2019 CASE Sta Barbara

    5/29

    y Prenatal

    y Mother started her Prenatal check-up at 4 monthsAOG at a LocalBrgy HealthCenter and regularly thereafter. No maternal illnesses

    y Natal

    y Born full term via NSD at the Health Center asssited by a midwifey Postnatal

    y No complications after birth

    y No previous hospitalizations

    y Feeding

    y Breastfed until present. Started supplementary feeding withformula milk at 4 months of age

    y Immunization

    y Completed c/o LHC

  • 8/6/2019 CASE Sta Barbara

    6/29

    y

    No previous hospitalizationsy No food and drug allergic reactions

  • 8/6/2019 CASE Sta Barbara

    7/29

    y No bronchial asthma

    y No allergies

    y No same lesions noted within the family

  • 8/6/2019 CASE Sta Barbara

    8/29

    y Patient was active and playful

    y VITAL SIGNSy CR: 112y RR: 36

    y Temp: 36.8

  • 8/6/2019 CASE Sta Barbara

    9/29

    y SKINy Brown and dry

    y White macular lesions diffusely distributed over the

    frontal, orbital and maxillary areas

  • 8/6/2019 CASE Sta Barbara

    10/29

    yHEENTy Normocephalic , whitish macular lesions on the face

    y Pearly white sclerae, pinkish conjuctiva

    y No ear and nasal dischargesy Moist lips and buccal mucosa

    y No cervical lymphadenopathies

  • 8/6/2019 CASE Sta Barbara

    11/29

    y CHESTy Symmetrical chest expansion

    y Clear breath sounds

    y Normal cardiac rate and regular rhythm

    y Adynamic precordium

    y No murmurs noted

  • 8/6/2019 CASE Sta Barbara

    12/29

    y ABDOMENy Round

    y Normoactive bowel sounds

    y Soft, non-tendery No masses

  • 8/6/2019 CASE Sta Barbara

    13/29

    y EXTREMITIESy Grossly normal

    y No lesions noted

    y Capillary refill time < 2 seconds

  • 8/6/2019 CASE Sta Barbara

    14/29

    y T/CPityriasis versicolor

    D

    ifferentialsy Vitiligo

    y Seborrheic dermatitis

  • 8/6/2019 CASE Sta Barbara

    15/29

    y KOH smear

    y Ketoconazole 2% cream OD x 2 weeks

    y Sulfur soap wash BID

  • 8/6/2019 CASE Sta Barbara

    16/29

  • 8/6/2019 CASE Sta Barbara

    17/29

    y chronic asymptomatic scaling epidermomycosisassociated with the superficial overgrowth of thehyphal form ofMalassezia furfur, characterized by

    well-demarcated scaling patches with variablepigmentation, occurring most commonly on the trunk.

  • 8/6/2019 CASE Sta Barbara

    18/29

    Etiologyy M. furfur(previously known as Pityrosporum ovale, P.

    orbiculare) is a lipophilic yeast that normally resides in

    the keratin of skin and hair follicles of individuals atpuberty and beyond. It is an opportunistic organism,causing pityriasis versicolor andMalassezia folliculitisand is implicated in the pathogenesis of seborrheic

    dermatitis.Malassezia infections are not contagious;rather, overgrowth of resident cutaneous flora occursunder certain favorable conditions.

  • 8/6/2019 CASE Sta Barbara

    19/29

    Age ofOnsety Young adults. Less common when sebum production

    is reduced or absent; tapers off during fifth and sixth

    decades.

  • 8/6/2019 CASE Sta Barbara

    20/29

    y Malassezia changes from the blastospore form to themycelial form under the influence of predisposingfactors. Dicarboxylic acids formed by enzymatic

    oxidation of fatty acids in skin surface lipids inhibittyrosinase in epidermal melanocytes and thereby leadto hypomelanosis. The enzyme is present in theorganism.

  • 8/6/2019 CASE Sta Barbara

    21/29

    Duration of Lesionsy Months to years.

    Skin Symptomsy Usually none.Occasionally, mild pruritus. Individuals

    with PV usually present because of cosmetic concernsabout the blotchy pigmentation.

  • 8/6/2019 CASE Sta Barbara

    22/29

  • 8/6/2019 CASE Sta Barbara

    23/29

    Distributiony Upper trunk, upper arms, neck, abdomen, axillae,

    groins, thighs, genitalia. Facial, neck, and/or scalp

    lesions occur in patients applying creams/ointments ortopical glucocorticoid preparations.

  • 8/6/2019 CASE Sta Barbara

    24/29

    Hypopigmented

    y Vitiligo, pityriasis alba, postinflammatoryhypopigmentation, tuberculoid leprosy.

    Scaling Lesionsy Tinea corporis, seborrheic dermatitis, pityriasis rosea,

    guttate psoriasis, nummular eczema.

  • 8/6/2019 CASE Sta Barbara

    25/29

  • 8/6/2019 CASE Sta Barbara

    26/29

  • 8/6/2019 CASE Sta Barbara

    27/29

  • 8/6/2019 CASE Sta Barbara

    28/29

    Diagnosisy Clinical findings, confirmed by positive KOH

    preparation findings.

    Course and Prognosisy Infection persists for years if predisposing conditions

    persist. Dyspigmentation persists for months afterinfection has been eradicated.

  • 8/6/2019 CASE Sta Barbara

    29/29

    Topical agents

    Selenium sulfide (2.5%) lotion or shampooApply daily to affected areas for 10 to 15 min, followed byshower, for 1 week

    Ketoconazoleshampoo Applied same as selenium sulfide shampoo

    Azole creams (ketoconazole, econazole, micronazole,clotrimazole)

    Apply qd or bid for 2 weeks

    Terbinafine 1% solution Apply bid for 7 days

    Systemic therapy

    Ketoconazole 400 mg stat (take 1 h before exercise)

    Fluconazole 400 mg stat

    Itraconazole 400 mg stat

    Secondaryprophylax

    is Ketoconazoleshampoo once or twice a weekSelenium sulfide (2.5%) lotion or shampoo

    Salicylic acid/sulfur bar

    Pyrithionezinc (bar or shampoo)

    Ketoconazole400 mg PO monthly